Skip to main content
. 2021 Mar 16;7(7):1956–1968. doi: 10.1021/acsinfecdis.1c00001

Table 3. Other Aminoguanidinesa.

compound R1 R2 IC50 D6 (nM) IC50 Dd2 (nM) IC50 Tm90–C2B (nM) IC50A6 (nM) IC50 cytotoxicity (μM) IVTI
24 H H 705 4298 >5000 581 >200 >100
25 4-OH H 143 240 286 278 39 >100
26 4-Ph H 15 87 71 33 >200 >100
27 4-NO2 H 96 198 247 85 >200 >100
28 4-NMe2 H 118 264 213 122 20 >100
29 4-COOH H >5000 >5000 >5000 >5000 >200 N/A
30 4-CONH2 H 527 405 727 516 42 80
31 4-SO2NH2 H >5000 >5000 >5000 >5000 >200 N/A
32 4-propynoxy H 102 199 376 153 >200 >100
33 4-morpholino H 131 329 295 116 >200 >100
34 3-tetrazole H 1645 >5000 >5000 4790 107 65
35 4-tetrazole H 838 >5000 >5000 >5000 >200 N/A
36 (2,2-difluoro) 2,3-dioxazole H 250 800 905 235 >200 >100
37 2,4-OMe, 5-Cl CH3 360 1247 1180 216 3 8
38 mono 2-Fb H 1028 2202 >5000 833 >200 >100
a

See Table 1 legend and Methods.

b

Compound 38 has a 2-fluoro substituent at only one R1 site. The other R1 site is unsubstituted (4-H).